Navigation Links
Stelex Announce QMS Module for Open Text's Livelink ECM
Date:10/18/2007

Quality Management System delivers unmatched out-of-the-box functionality

BENSALEM, Pa., Oct. 18 /PRNewswire-FirstCall/ -- Stelex-The Validation Group, Inc. (Stelex), the market leader in providing enterprise-wide compliance solutions to the regulated industries, today announced the Quality Management System (QMS) module for Livelink ECM from Open Text(TM) Corporation, the largest independent provider of Enterprise Content Management (ECM) software and solutions. QMS for Livelink ECM will be demonstrated at Open Text's North American user conference LiveLinkUp 2007, in Orlando, Florida.

This groundbreaking product brings together Open Text's powerful Livelink ECM platform with Stelex' deep knowledge of the Life Sciences industry and regulatory issues. The QMS module allows regulated businesses to rapidly deploy a quality management system that meets the FDA's most stringent electronic record-keeping requirements.

The QMS module gives regulated industries, including pharmaceutical, medical device, biotechnology, and diagnostic companies, a flexible and expandable solution to manage quality issues and initiatives. QMS provides a fully integrated solution that complies with the electronic records provisions of the U.S. Food and Drug Administration's (FDA) 21 CFR Part 11, while addressing the needs for Pharmaceutical Best Practice (21 CFR 210 and 211), Biological Best Practice (21 CFR 600-680) and Medical Device Best Practice (21 CFR 820). The system is also configurable to meet the Quality System requirements of ISO9000, EPA QA/G-1, and similar standards governing regulated industries.

Livelink ECM - QMS integrates the key processes required by regulated industries, including Corrective and Preventive Actions (CAPA), Audits, Training and Regulated Document Management into an enterprise-level solution. Documents that are needed for audits, CAPA, training, etc. can be created, reviewed, approved, edited and maintained within the Quality Management System repository. Using the Livelink ECM platform, can assist in savings in hardware, software and maintenance costs throughout the system lifecycle.

"This highly configurable product provides out-of-the-box functionality that is unmatched in the industry," said Jim Day, Open Text Partner Manager at Stelex.

LiveLinkUp 2007

Open Text's LiveLinkUp 2007 Orlando Conference brings together customers, partners and industry leaders to review the latest in ECM strategies and technologies. LiveLinkUp 2007 is being held this year on October 23 - 25 at the JW Marriott Orlando Grande Lakes, Orlando, Florida. To see a live demonstration, visit Stelex in the Table Top Booth area. For more information, go to: http://livelinkup.opentext.com/orlando/2007/

About Stelex

Stelex is a consulting firm providing enterprise-wide compliance solutions to regulated industries in the Pharmaceutical, Medical Device, Diagnostic and Biotechnology sectors for over 20 years. The firm delivers a comprehensive suite of Validation, Technology, Regulatory and Business solutions. Learn more about Stelex at http://www.stelex.com.

Stelex is a subsidiary of Vital Signs, Inc. (Nasdaq: VITL). Vital Signs, Inc. and its subsidiaries design, manufacture and market primarily single-use medical products for the anesthesia, respiratory/critical care, interventional cardiology/radiology and sleep/ventilation markets, achieving the number one market share position in five of its major product categories. Vital Signs is ISO 9001 certified and has CE Mark approval for its products.

All statements in this press release other than historical statements constitute Forward Looking Statements under the Private Securities Litigation Reform Act of 1995. Actual results could differ materially from such statements as a result of a variety of factors including factors referred to by Vital Signs in its Annual Report on Form 10-K for the year ended September 30, 2006.

For more information, please contact:

Stelex

Jim Day

Phone: 215-352-1173

jday@stelex.com

http://www.stelex.com

Open Text

Michele Stevenson

mstevens@opentext.com


'/>"/>
SOURCE Stelex
Copyright©2007 PR Newswire.
All rights reserved

Related biology technology :

1. Speaker announces business members of IT Task Force
2. Doyle announces technology tax credits for Berbee
3. Doyle announces new energy, global warming policies
4. Doyle, WARF announce partnership to lure stem cell companies
5. Doyle announces $80M renewable energy strategy
6. GE announces first installation of Discovery VCT
7. UWM announces winners of RGI awards
8. Third Wave announces two senior management appointments
9. Mirus announces new method for making antibodies
10. Merge announces sofware updates, upcoming acquisition
11. Small Tree announces ethernet solution for Apple Xserv G5
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... WA (PRWEB) , ... June 23, 2016 , ... ... announces the release of its second eBook, “Clinical Trials Patient Recruitment and Retention ... recruitment and retention in this eBook by providing practical tips, tools, and strategies ...
(Date:6/23/2016)... , June 23, 2016   Boston Biomedical ... novel compounds designed to target cancer stemness pathways, ... been granted Orphan Drug Designation from the U.S. ... of gastric cancer, including gastroesophageal junction (GEJ) cancer. ... designed to inhibit cancer stemness pathways by targeting ...
(Date:6/23/2016)... June 23, 2016 A person commits a crime, ... scene to track the criminal down. An outbreak ... and Drug Administration (FDA) uses DNA evidence to track down ... Sound far-fetched? It,s not. The FDA has increasingly used ... investigations of foodborne illnesses. Put as simply as possible, whole ...
(Date:6/23/2016)... ... June 23, 2016 , ... Charm Sciences, Inc. ... test has received AOAC Research Institute approval 061601. , “This is another AOAC-RI ... stated Bob Salter, Vice President of Regulatory and Industrial Affairs. “The Peel Plate ...
Breaking Biology Technology:
(Date:4/28/2016)... First quarter 2016:   , Revenues amounted ... quarter of 2015 The gross margin was 49% (27) ... the operating margin was 40% (-13) Earnings per share ... operations was SEK 249.9 M (21.2) , Outlook   ... M. The operating margin for 2016 is estimated to ...
(Date:4/15/2016)... Research and Markets has announced ... 2016-2020,"  report to their offering.  , ... global gait biometrics market is expected to grow ... 2016-2020. Gait analysis generates multiple variables ... to compute factors that are not or cannot ...
(Date:3/29/2016)... March 29, 2016 LegacyXChange, Inc. ... "LEGX" and SelectaDNA/CSI Protect are pleased to announce our ... in a variety of writing instruments, ensuring athletes signatures ... created collectibles from athletes on LegacyXChange will be assured ... the DNA. Bill Bollander , CEO ...
Breaking Biology News(10 mins):